Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Impact of fungal drug transporters on fungicide sensitivity, multidrug resistance and virulence
2006
Vulvovaginal candidosis
2007 Standout
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
2012
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole
1994
Cure of experimental Chagas' disease by the bis-triazole DO870 incorporated into 'stealth' polyethyleneglycol-polylactide nanospheres
2001
Candida Urinary Tract Infections—Diagnosis
2011
Trypanosoma cruzi Contains Major Pyrophosphate Stores, and Its Growth in Vitro and in Vivo Is Blocked by Pyrophosphate Analogs
1999
Funicone-related Compounds, Potentiators of Antifungal Miconazole Activity, Produced by Talaromyces flavus FKI-0076.
2002 StandoutNobel
In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections.
1999
Effects of Trifluralin on Trypanosoma cruzii in vitro and in vivo
1999
Systemically Administered Antifungal Agents
1992
Virulence factors of Candida albicans
2001 Standout
A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease
2000
Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal Therapy
1992
Anti-CandidaDrugs — The Biochemical Basis for Their Activity
1987
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
2003 Standout
Candida Urinary Tract Infection: Pathogenesis
2011
Controversial aspects in the management of vulvovaginal candidiasis
1994
Fluconazole Therapy for Experimental Cryptococcosis and Candidiasis in the Rabbit
1990
Candida albicanspathogenicity mechanisms
2013 Standout
Recent developments in pradimicin-benanomicin and triazole antibiotics
1997
Genetic susceptibility to vaginal candidiasis
2003
Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
2016
Fungal morphogenesis and host invasion
2002
Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection
1998
Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa
2003
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Botrytis cinerea : the cause of grey mould disease
2007 Standout
Drug resistance in human pathogenic fungi
1992
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Sulphur-containing derivatives structurally related to fenoxycarb are potent growth inhibitors against the intracellular form of Trypanosoma cruzi
2000
Gene Therapy for Brain Tumors
1995
Structure–function relationships of immunostimulatory polysaccharides: A review
2015 Standout
Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system
1988 Standout
The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruzi
1993
Studies on wheat bran Arabinoxylan for its immunostimulatory and protective effects against avian coccidiosis
2012
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutants ofCryptococcus neoformans
1990
In vitro and in vivo evaluation of antifungal agents
1989
Toxoplasma gondii: from animals to humans
2000 Standout
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans
2000
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
A plastid organelle as a drug target in apicomplexan parasites
1997 StandoutNature
Immunity to fungal infections
2011 Standout
THE PROTECTIVE IMMUNE RESPONSE AGAINST VAGINAL CANDIDIASIS: LESSONS LEARNED FROM CLINICAL STUDIES AND ANIMAL MODELS
2002
Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene
1999
Newly documented antimicrobial activity of quinolones
1991
Antifungal agents: mechanisms of action
2003 Standout
Mechanisms of resistance to fungicides in field strains of Botrytis cinerea
2002
Toxic Effects of Benomyl on the Ultrastructure during Spermatogenesis of the Earthworm Eisenia fetida
2001
Nonfilamentous C. albicans Mutants Are Avirulent
1997 Standout
The integrated stress response
2016 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Exploitation of natural products as an alternative strategy to control postharvest fungal rotting of fruit and vegetables
2004 Standout
In Vitro Antiproliferative Effects and Mechanism of Action of the New Triazole Derivative UR-9825 against the Protozoan ParasiteTrypanosoma(Schizotrypanum)cruzi
2000
In vitro biosynthesis and core glycosylation of the histidine-rich protein of Plasmodium lophurae
1983 StandoutNobel
DRUG RESISTANCE IN PROTOZOA
1959
Ganglioside treatment of acuteTrypanosoma cruziinfection in mice promotes long-term survival and parasitological cure
1999
Oocyst wall formation and composition in coccidian parasites
2009
Synthesis of Isocoumarins and α-Pyrones via Electrophilic Cyclization
2003 Standout
Efficacy of D0870 treatment of experimental Candida vaginitis
1997
Azole resistance inCandida albicans
1986
Ganglioside treatment of acute Trypanosoma cruzi infection in mice promotes long-term survival and parasitological cure
1999
A Critical Review on Chagas Disease Chemotherapy
2002 Standout
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Recent Developments in Molecular Genetics of Candida Albicans
2000
The enhanced folic and folinic acid contents of erythrocytes infected with malaria parasites
1959
Antiparasitic Effects of the Intra-Golgi Transport Inhibitor Megalomicin
1998
Antifungal susceptibility testing
1993
Characterization of an azole-resistant Candida glabrata isolate
1992
Activities of the triazole D0870 in vitro and against murine blastomycosis
1993
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Design and Synthesis of Aryloxyethyl Thiocyanate Derivatives as Potent Inhibitors ofTrypanosoma cruziProliferation
2000
Structure−Activity Relationship of New Growth Inhibitors of Trypanosoma cruzi
1998
α-Fluorinated Ethers, Thioethers, and Amines: Anomerically Biased Species
2005
Azole resistance in Candida albicans.
1986
Differentiation Between Women With Vulvovaginal SymptomsWho are Positive or Negative for Candida Species by Culture
2001
Current and Emerging Azole Antifungal Agents
1999 Standout
PUTATIVE VIRULENCE FACTORS OF CANDIDA ALBICANS
1991
The lipid composition and permeability to azole of an azole- and polyene-resistant mutant ofCandida albicans
1987
Ultrastructural Studies on the Sporulation of Oocysts of Toxoplasma Gondii
1979
Interaction of azole derivatives with cytochrome P‐450 isozymes in yeast, fungi, plants and mammalian cells
1987
The action of itraconazole and ketoconazole on growth and sterol synthesis inAspergillus fumigatusandAspergillus niger
1985
Ultrastructural Studies on the Sporulation of Oocysts of Toxoplasma Gondii
1979
Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata
1995
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts
1993
The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment
2020
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
1995
Dihydrofolate reductase inhibitors as potential drugs
1981
Induction of Resistance to Azole Drugs in Trypanosoma cruzi
1998
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance
1996
Future prospects for the chemotherapy of Chagas' disease.
1999
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Bisphosphonates Inhibit the Growth ofTrypanosomabrucei,Trypanosomacruzi,Leishmaniadonovani,Toxoplasmagondii, andPlasmodiumfalciparum: A Potential Route to Chemotherapy
2001
Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents
1992
Design, Synthesis and Evaluation of d-Homophenylalanyl Epoxysuccinate Inhibitors of the Trypanosomal Cysteine Protease Cruzain
2000
Clinical Pharmacokinetics of Systemic Antifungal Drugs
1983
Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain
1995
Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
1999
Profile of Candida albicans- Secreted Aspartic Proteinase Elicited during Vaginal Infection
2005
Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis
1985
Chemical structure of the galactomannan from the cell wall of Aspergillus niger.
1977
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Characterization of Mechanisms of Fluconazole Resistance in a Candida albicans Isolate from a Japanese Patient with Chronic Mucocutaneous Candidiasis
2004
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Anticoccidial Drugs: Growth and Performance Depressing Effects in Young Chickens
1982
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits
1986
Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria
2003 Standout
Multicenter evaluation of four methods of yeast inoculum preparation
1988
Validating targets for antiparasite chemotherapy
1997
Aspergillus fumigatusand Aspergillosis
1999 Standout
Overview of medically important antifungal azole derivatives
1988
Collaborative investigation of variables in susceptibility testing of yeasts
1990
The fine structure of the conoid of sporozoa and related organisms
1970
Experimental models in antifungal chemotherapy
1998
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1
1993
Solid-Phase Library Synthesis, Screening, and Selection of Tight-Binding Reduced Peptide Bond Inhibitors of a RecombinantLeishmaniamexicanaCysteine Protease B
2002 StandoutNobel
Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes
1987
Structures ofToxoplasma gondiiTachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts
1998 Standout
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Activities of the Triazole Derivative SCH 56592 (Posaconazole) against Drug-Resistant Strains of the Protozoan Parasite Trypanosoma ( Schizotrypanum ) cruzi in Immunocompetent and Immunosuppressed Murine Hosts
2000
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Toxic effects of carbendazim at low dose levels in male rats
2008
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells
1984
Drug Resistance in Leishmaniasis
2006 Standout
Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors
1998
Multidrug Resistance in Botrytis cinerea Associated with Decreased Accumulation of the Azole Fungicide Oxpoconazole and Increased Transcription of the ABC Transporter Gene BcatrD
2001
Inhibition of Folate Biosynthesis and Function as a Basis for Chemotherapy
1965 StandoutNobel
Rapid Detection of Vaginal Candida Species by Newly Developed Immunochromatography
2009 StandoutNobel
Antifungal alkyl pyrones of Trichoderma harzianum
1987
Design, Synthesis, and Biological Evaluation of Phenylamino-Substituted 6,11-Dihydro-dibenzo[b,e]oxepin-11-ones and Dibenzo[a,d]cycloheptan-5-ones: Novel p38 MAP Kinase Inhibitors
2006
Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis
1997
Role of the Mitogen-Activated Protein Kinase Hog1p in Morphogenesis and Virulence of Candida albicans
1999
Genetic basis of resistance to benzimidazole and dicarboximide fungicides in Botryotinia fuckeliana (Botrytis cinerea)
1991
Works of J Ryley being referenced
Mode of action of antifungal agents
1984
Laboratory studies with some older anticoccidials
1976
Activity of ICI 195,739—a Novel, Orally Active Bistriazole—in Rodent Models of Fungal and Protozoal Infections
1988
A multi-infection model for antifungal screening in vivo
1988
Pathogenicity ofCandida albicanswith particular reference to the vagina
1986
Experimental Approaches to Antifungal Chemotherapy
1981
Azole resistance inCandida albicans
1984
The antimalarial activity of some quinolone esters
1970
Candida albicans—do mycelia matter?
1990
Tricyclic aryl-substituted anticoccidial azauracils
1978
Azole resistance in Candida albicans.
1984
Ultrastructural studies on the sporozoite of Eimeria tenella
1969
THE MODE OF ACTION OF PROGUANIL AND RELATED ANTIMALARIAL DRUGS
1953
Kidney Function in Experimental Systemic Candidosis of Mice/Die Nierenfunktion bei experimenteller systemischer Candidose der Maus
1988
Quantification of vaginalCandida albicansinfections in rodents
1986
Chemotherapy of Chicken Coccidiosis
1973
Laboratory studies with some recent anticoccidials
1975
Methods in coccidiosis research: separation of oocysts from faeces
1976
Life cycle studies withEimeria magna Pérard, 1925
1976
The molecular structures of a glucan and a galactan synthesised by prototheca zopfii
1973
Screening for and Evaluation of Anticoccidial Activity
1980
Chemotherapy of Fungal Diseases
1990
Amylopectin, the Storage Polysaccharide of the Coccidia Eimeria brunetti and E. tenella
1969
Cure of Short- and Long-Term Experimental Chagas' Disease Using D0870
1996 Science